A qualitative investigation of the supportive care experiences of people living with pancreatic and oesophagogastric cancer

Nadia N. Khan, Ashika Maharaj, Sue Evans, Charles Pilgrim, John Zalcberg, Wendy Brown, Paul Cashin, Daniel Croagh, Natasha Michael, Jeremy Shapiro, Kate White and Liane Ioannou

Pancreatic and oesophagogastric (OG) cancers have a dismal prognosis and high symptom burden, with supportive care forming an integral component of the care provided to patients. This study aimed to explore the supportive care experiences of patients and caregivers living with pancreatic and OG cancers in order to identify perceived opportunities for improvement.

Systematic review of the predictors
of health service use in pancreatic cancer

Nadia N Khan, Tennille Lewin, Amy Hatton, Charles Pilgrim, Liane Ioannou,

Luc te Marvelde, John Zalcberg, Sue Evans

Despite representing only 2.5% of cancers across the world, in 2018, pancreatic cancer contributed to 4.5% of all cancer-related deaths worldwide. The prognosis for pancreatic cancer is extremely poor, with 5-year survival rates ranging between 5 to 15%, globally. A poor prognosis is often due to the cancer not displaying any cardinal symptoms during early stages of disease. Coupled with a poor chance of survival, patients also experience high symptom burden and poor quality of life.